1. Home
  2. GORV vs NEUP Comparison

GORV vs NEUP Comparison

Compare GORV & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GORV
  • NEUP
  • Stock Information
  • Founded
  • GORV 1976
  • NEUP 1996
  • Country
  • GORV United States
  • NEUP United States
  • Employees
  • GORV N/A
  • NEUP N/A
  • Industry
  • GORV Retail-Auto Dealers and Gas Stations
  • NEUP
  • Sector
  • GORV Consumer Discretionary
  • NEUP
  • Exchange
  • GORV Nasdaq
  • NEUP Nasdaq
  • Market Cap
  • GORV 9.3M
  • NEUP 10.3M
  • IPO Year
  • GORV 2015
  • NEUP N/A
  • Fundamental
  • Price
  • GORV $1.12
  • NEUP $4.83
  • Analyst Decision
  • GORV
  • NEUP Strong Buy
  • Analyst Count
  • GORV 0
  • NEUP 2
  • Target Price
  • GORV N/A
  • NEUP $28.00
  • AVG Volume (30 Days)
  • GORV 153.4K
  • NEUP 4.8M
  • Earning Date
  • GORV 11-14-2025
  • NEUP 11-21-2025
  • Dividend Yield
  • GORV N/A
  • NEUP N/A
  • EPS Growth
  • GORV N/A
  • NEUP N/A
  • EPS
  • GORV N/A
  • NEUP N/A
  • Revenue
  • GORV $662,952,000.00
  • NEUP $15,649,448.00
  • Revenue This Year
  • GORV $15.65
  • NEUP N/A
  • Revenue Next Year
  • GORV $20.54
  • NEUP N/A
  • P/E Ratio
  • GORV N/A
  • NEUP N/A
  • Revenue Growth
  • GORV N/A
  • NEUP N/A
  • 52 Week Low
  • GORV $0.80
  • NEUP $2.90
  • 52 Week High
  • GORV $58.80
  • NEUP $126.00
  • Technical
  • Relative Strength Index (RSI)
  • GORV 25.39
  • NEUP 37.04
  • Support Level
  • GORV $0.80
  • NEUP $4.09
  • Resistance Level
  • GORV $2.22
  • NEUP $4.50
  • Average True Range (ATR)
  • GORV 0.15
  • NEUP 0.66
  • MACD
  • GORV -0.09
  • NEUP 0.01
  • Stochastic Oscillator
  • GORV 18.75
  • NEUP 24.07

About GORV Lazydays Holdings Inc.

Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

Share on Social Networks: